AKT1 and leukemia: Various small molecule inhibitors, including those targeting protein kinases, epigenetic modifiers, PI3K/Akt/mTOR signaling, and apoptosis regulators, have demonstrated potential synergistic effects when combined with CAR-T therapy for leukemia [110].